atacand

Generic: candesartan cilexetil

Labeler: ani pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name atacand
Generic Name candesartan cilexetil
Labeler ani pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

candesartan cilexetil 16 mg/1

Manufacturer
ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 62559-642
Product ID 62559-642_6ae461eb-f06a-4bf1-b6da-73d66b99b33c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020838
Listing Expiration 2026-12-31
Marketing Start 2018-10-01

Pharmacologic Class

Classes
angiotensin 2 receptor antagonists [moa] angiotensin 2 receptor blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62559642
Hyphenated Format 62559-642

Supplemental Identifiers

RxCUI
153822 153823 577776 577785 577787 639537 639539 639543
UPC
0362559643306 0362559642309 0362559640305 0362559641302
UNII
R85M2X0D68

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atacand (source: ndc)
Generic Name candesartan cilexetil (source: ndc)
Application Number NDA020838 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 16 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (62559-642-30)
  • 90 TABLET in 1 BOTTLE (62559-642-90)
source: ndc

Packages (2)

Ingredients (1)

candesartan cilexetil (16 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6ae461eb-f06a-4bf1-b6da-73d66b99b33c", "openfda": {"upc": ["0362559643306", "0362559642309", "0362559640305", "0362559641302"], "unii": ["R85M2X0D68"], "rxcui": ["153822", "153823", "577776", "577785", "577787", "639537", "639539", "639543"], "spl_set_id": ["94a59260-d2b6-464a-b5b9-bbc599e57e10"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (62559-642-30)", "package_ndc": "62559-642-30", "marketing_start_date": "20181001"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (62559-642-90)", "package_ndc": "62559-642-90", "marketing_start_date": "20181001"}], "brand_name": "ATACAND", "product_id": "62559-642_6ae461eb-f06a-4bf1-b6da-73d66b99b33c", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "62559-642", "generic_name": "Candesartan Cilexetil", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATACAND", "active_ingredients": [{"name": "CANDESARTAN CILEXETIL", "strength": "16 mg/1"}], "application_number": "NDA020838", "marketing_category": "NDA", "marketing_start_date": "20181001", "listing_expiration_date": "20261231"}